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ABSTRACT
Introduction The Modification of Diet, Exercise and 
Lifestyle (MODEL) study aims to examine the impact of 
providing visualisation and pictorial representation of 
advanced structural vascular disease (abdominal aortic 
calcification), on ‘healthful’ improvements to diet and 
lifestyle. This paper reports the protocol for the process 
evaluation for the MODEL study.
Methods and analysis The overall aim of the process 
evaluation is to understand the processes that took place 
during participation in the MODEL study trial and which 
elements were effective or ineffective for influencing 
‘healthful’ behavioural change, and possible ways of 
improvement to inform wider implementation strategies. 
A mixed- method approach will be employed with the use 
of structured questionnaires and semistructured in- depth 
interviews. All 200 participants enrolled in the trial will 
undertake the quantitative component of the study and 
maximum variation sampling will be used to select a 
subsample for the qualitative component. The sample size 
for the qualitative component will be determined based on 
analytical saturation. Interviews will be digitally recorded 
and transcribed verbatim. Qualitative data will be analysed 
thematically and reported according to the Consolidated 
Criteria for Reporting Qualitative Research (COREQ) 
guidelines.
Ethics and dissemination The MODEL study process 
evaluation has received approval from Edith Cowan 
University Human Research Ethics Committee (Project 
Number: 20513 HODGSON). Written informed consent 
will be obtained from all participants before they are 
included in the study. The study results will be shared 
with the individuals and institutions associated with 
this study as well as academic audiences through 
peer- reviewed publication and probable presentation at 
conferences.
Trial registration number ACTRN12618001087246.
INTRODUCTION
Suboptimal lifestyle choices and risky 
behaviours are the leading causes of athero-
sclerosis which, in turn, precipitates most 
cardiovascular disease (CVD) events, such 
as heart attacks and strokes.1–3 Most CVD- 
related events can be prevented or delayed 
by improvements to lifestyle factors including 
Strengths and limitations of this study
 ► A comprehensive evaluation of all components/el-
ements of a complex intervention will be achieved 
using a mixed- methods approach.
 ► Maximum variation sampling will be used to select 
participants for interview to maximise the diversity 
relevant to the research objectives.
 ► A reliable method of inquiry will be employed using 
standardised set of questions for the survey (quan-
titative component).
 ► Qualitative findings will give rich insights into per-
spectives of participants engaged in the Modification 
of Diet, Exercise and Lifestyle study intervention.
 ► A limitation of this study is the risk of recall bias 
(unintentional and intentional responder bias) due 
to poor memory or the life- threating/life- changing 
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diet, physical activity and the cessation of smoking.2 
Despite the known benefits of these factors, few people 
take up or adhere to existing lifestyle recommendations. 
Therefore, strategies to encourage individuals to initiate 
and adhere to long- term dietary and lifestyle changes are 
urgently needed. One strategy that offers promise in this 
regard is to provide individuals with visual information 
about their blood vessel health using vascular imaging 
modalities. New technologies have enabled information 
about blood vessel health to be provided to study partic-
ipants,4–7 and a randomised controlled trial (RCT) of 
the impact of such information on behaviour change is 
forthcoming. This RCT holds great promise for modi-
fying behaviour in older individuals with no history of 
clinical CVD. The purpose of this protocol is to overview 
the process evaluation that will be embedded within the 
Modification of Diet, Exercise and Lifestyle (MODEL) 
randomised control trial.
Critics of RCTs contend that there’s a set of ‘positivist’ 
assumptions that drive RCTs which are discordant with 
understanding the context of complex interventions.8 
Berwick,9 Clark et al,10 Pawson and Tilley11 opined that 
there is an oversimplification of cause and effect in RCTs 
of complex interventions and investigators often ignore 
the agency of participants and implementers as well as 
the context in which the intervention is experienced and 
implemented. There is emerging evidence to support the 
line of reasoning that a more critical realist framework 
should guide the conduct of RCTs of complex interven-
tions. This will enable methods to be applied and inter-
preted critically while social realities are viewed as valid 
objects of scientific study.12 The Medical Research Council 
(MRC) framework13 14 does not support the arguments 
against RCTs but acknowledges that ‘effect sizes’ alone 
are not sufficient, and that process evaluations should be 
conducted alongside of RCTs to limit biases when esti-
mating effects. Process evaluations provide insight into 
implementation processes and mechanisms of impact 
in complex interventions, assisting with interpretation 
of overall study outcomes.13 15 16 They can also provide 
detailed information that could support the interpreta-
tion of causality by a systematic reviewer, practitioner or 
policymaker.13 14 Process evaluations have been demon-
strated to be useful at the time of explaining trial results 
for complex interventions.17–20
For example, van Dongen et al17 used a comprehen-
sive process evaluation plan to examine the delivery and 
receipt of a diabetes prevention intervention by evalu-
ating the intervention components that contributed to 
effective prevention of type 2 diabetes.17 They concluded 
that it is feasible to implement a diabetes prevention inter-
vention in Dutch primary healthcare after completion 
and reporting results of the process evaluation.17 Another 
process evaluation assessed the quality of the execution 
of a programme for a self- management intervention for 
people with polyarthritis from the participants’ perspec-
tive.12 The process evaluation results identified the extent 
to which specific exercises and programme were highly 
valued and therefore the need to use various compo-
nents such as writing exercises, use of role models and 
combined individual trajectory and group training to 
create an attractive intervention for a broad audience.18 
Also, the ProActive study (a physical activity intervention) 
process evaluation19 20 identified various reasons for trial 
outcomes using an explicit a priori hypothesised causal 
model while the Welsh National Exercise Referral Scheme 
intervention21 process evaluation reported that there 
were limitations in communication, training and support 
which impacted the fidelity of some components.21 More-
over, a process evaluation for an adolescent sexual health 
programme intervention in Tanzania reported the extent 
to which young people were engaged with the programme 
and quality of programme implementation.22 All of these 
process evaluation examples have reported on the impact 
of contextual factors on the effectiveness of an interven-
tion22 as well as contextual factors and implementers’ 
actions that shaped delivery21 and the fidelity of imple-
mentation19 using mixed- methods21 22 or quantitative 
approaches.19
This study will evaluate the implementation, mecha-
nisms of impact and key contextual factors involved in 
outcomes of the MODEL study using a mixed- method 
approach. This will enable the investigators to better 
understand how and why the intervention was effective or 
ineffective, as well as identify contextual factors involved 
in outcomes to inform wider implementation strategies. 
It will also be useful in the interpretation of trial results.
The MODEL study
The MODEL study will investigate whether providing 
individuals with visualisation and pictorial represen-
tation of structural vascular disease in the abdominal 
aorta can influence short- term fruit and vegetable intake 
(primary outcome), adherence to other dietary recom-
mendations (eg, sodium, fibre, whole grains, seeds and 
nuts intake), physical activity, gut health, physical func-
tion and psycho- emotional and mental health outcomes 
(motivation to initiate behavioural change, perceived risk 
of CVD, depression, quality of life). All participants will 
have their abdominal aortic calcification (AAC) assessed 
from a lateral spine image captured using dual- energy 
X- ray absorptiometry at baseline. The MODEL study will 
include a total of 200 (n=100 control group; n=100 inter-
vention group) ambulant community- dwelling Australian 
men and women, aged 60–80 years, recruited from the 
general population in metropolitan Perth, Melbourne 
and surrounding areas in Australia. A detailed explana-
tion of the methods for the MODEL study is provided in 
the protocol for the MODEL study (Radavelli- Bagatini et 
al in press).
Process evaluation
The process evaluation will ascertain the participants’ 
views on the counselling session (including information 
about atherosclerosis and diet and lifestyle advice provided 
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their blood vessel disease results (image and illustrative 
information). It will also be useful in terms of evaluating 
the factors in the community, socioeconomic context, 
participant characteristics or other situational issues, that 
may influence the process of changing behaviour. This 
will inform future methods, intervention designs and 
theories23–25 in addition to ascertaining the direction of 
the intervention’s key components to produce the antici-
pated results.13 14
Aim
The overall aim of the process evaluation is to under-
stand the processes that took place during participation 
in the MODEL study trial and which elements were effec-
tive or ineffective for influencing ‘healthful’ behavioural 
change, and possible ways of improvement to inform 
wider implementation strategies.
Specific objectives :
1. To evaluate the resources, structures and the proce-
dures used to deliver the MODEL study intervention 
from the perspective of participants.
2. To assess participants’ responses to the MODEL 
study intervention and mediating processes which may 
influence the process of changing behaviour and subse-
quent changes in outcomes.
3. To better understand the contribution of external 
factors which may influence intervention outcomes (ie, 
behaviour change).
The research objectives for the process evaluation were 
structured around the three domains of implementation, 
mechanisms of impact and context. This is required to 
assess the intervention using a standardised process evalu-
ation framework.14 The conceptual framework will aid us 
to address the three objectives of the process evaluation.
Conceptual Framework for the Process Evaluation
This process evaluation design was informed by the guid-
ance for process evaluations as specified by the MRC.13 14 
Specifically, the process evaluation will examine three key 
features—implementation, mechanisms of impact and 
context—to understand the processes through which 
one can achieve outcomes (figure 1). Table 1 further 
illustrates the domain/constructs, objectives and how the 
objectives will be addressed.
PROCESS EVALUATION METHODS
Design considerations
The intervention is expected to influence behavioural 
change based on certain mediators/moderators such as 
perceptions of severity and susceptibility. Factors in the 
community, social/political context or other situational 
issues have been associated with tobacco use, physical 
inactivity and poor diet.26–31 Therefore, in the course 
of the intervention, situations which may influence the 
outcome of the intervention such as family, friends, 
Figure 1 Key functions of MODEL study process evaluation and relations among them. Adapted from Moore et al14 and 
modified for the MODEL study process evaluation. AAC, abdominal aortic calcification; CVD, cardiovascular disease; MODEL, 
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general practitioner (GP), cultural differences, finances 
as well as access to information (internet, social media) 
will be part of the context to be explored. Participants 
perceived risk of CVD, perceptions of CVD severity and 
susceptibility and perceived self- efficacy is also expected 
to be key mediators of behaviour change. While we 
anticipate that these influences will be relevant contex-
tual factors and mediators/moderators, we remain open 
to other potential contextual factors and mediators/
moderators obtained from the qualitative interviews 
where participants describe their experiences in their 
own words. Health- related behavioural change will be 
explained and predicted in this study using the social- 
psychological health behavioural change model known as 
the Health Belief Model.32
Overall design
The process evaluation will employ a mixed- method 
approach using both qualitative and quantitative methods 
of data collection and analysis. This will include the use of 
a structured questionnaire and semistructured in- depth 
interviews (to be administered to participants). There are 
several reasons for focusing on the perspectives of partici-
pants. The intervention is intended to act on the perspec-
tive of participants; their perception of the effectiveness 
of the components is critical to identify key components 
and effective techniques. In other words, the intervention 
is likely to depend on participants’ interpretations of, and 
reactions to, the intervention; hence, it is important to 
consider those perspectives. Also, the participants will not 
be passive receivers of the intervention and it will likely 
influence their circumstances, attitudes, beliefs, social 
norms and resources.14
All participants recruited for the MODEL study will 
respond to a questionnaire that has been designed for 
the process evaluation. Maximum variation sampling 
(also known as maximum diversity sampling or maximum 
heterogeneity sampling),33 a form of purposeful sampling, 
will be used to select participants with characteristics that 
maximise the diversity relevant to the research objec-
tives. This sampling will be used to assess what influ-
ences behaviour change among participants at Perth and 
Melbourne study sites. Participant characteristics such as 
ethnicity/culture, age, profession, household income as 
well as sources of income will be considered in the selec-
tion. The sample size will be determined based on analyt-
ical saturation.34 This is commonly taken to indicate that, 
based on the data that have been collected or analysed, 
further data collection and/or analysis are unnecessary.34 
We anticipate achieving saturation with 15–20 trial partic-
ipant interviews.
The research team will be composed of investigators 
with diverse backgrounds, such as psychology, nutrition, 
exercise physiology, social work, with some being part of 
the core team of the RCT (MODEL study).
Table 1 Domain/constructs, objectives and how the objectives will be addressed
Domain/constructs
Description of domains/ 
constructs Objectives How the objectives will be addressed
Implementation The structures, resources and 
the procedures used to deliver 
the intervention.
To evaluate the resources, 
structures, and the 
procedures used to 
deliver the MODEL study 
intervention from the 
perspective of participants.
Explore participants’ views on the clarity 
of information in the videos, counselling 
process and any other materials or 
resources provided during participation.
Mechanisms of 
impact
Participant responses to the 
intervention and mediating 
processes that may influence 
subsequent changes in 
outcomes.
To assess participants’ 
responses to the MODEL 
study intervention and 
mediating processes which 
may influence the process 
of changing behaviour and 
subsequent changes in 
outcomes.
1. Response to intervention—Gathering 
information on participants’ reaction 
to their level and extent of their blood 
vessel disease results (image and 
illustrative information), videos and 
cardiovascular risk factors.
2. Mediators—Gathering information 
related to perceived risk of CVD, 
perceptions of CVD severity and 
susceptibility and perceived self- 
efficacy.
Context External factors that may 
influence intervention 
implementation
To better understand the 
contribution of external 
factors which may influence 
intervention outcomes (ie, 
behavioural change).
Identify participant characteristics (age, 
gender, employment status), community, 
socioeconomic status or other situational 
issues outside of the intervention such 
as influence from family and friends, 
information from their general practitioner, 
as well as access to information (internet, 
social media) that support change (or not).
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Data Collection
Qualitative data will be collected using a semi- structured 
in- depth interview. A semistructured interview guide 
(online supplemental appendix 1) will be used to enquire 
about experiences of participants in terms of clarity of 
information, counselling, reaction to their blood vessel 
disease results (image and illustrative information) and 
cardiovascular risk factors. Interviews will be conducted 
approximately 1 month after participants complete the 
baseline component of the intervention. Participants 
must complete a 30 min counselling session at baseline 
(including watching three educational videos, receiving a 
booklet with diet and lifestyle information), and receive 
their AAC results and baseline biochemistry results. 
Quantitative data will be collected using a question-
naire (Postcounselling health status questionnaire—on-
line supplemental appendix 2). This questionnaire will 
be used to obtain information on the perceived risk of 
CVD, perceptions of CVD severity and susceptibility and 
perceived self- efficacy. It will be administered immedi-
ately after participants complete their baseline counsel-
ling session.
The use of semistructured interviews will provide flex-
ibility in exploring relevant and interesting matters as 
raised by participants. This will enable prespecified areas 
to be explored and remain open to exploring other ideas 
and thoughts that will arise in the interview.35 Table 2 
presents information on study objectives, sample, data 
collection tools and what data will be gathered at each 
stage of the trial.
All consenting trial participants will be invited to 
respond to a questionnaire with a sub- sample invited to 
participate in an interview.
Investigators involved in data collection will discuss the 
aims of the questionnaire/interviews and provide infor-
mation on any potential benefits and harm of participa-
tion. Participants will be assured of the confidentiality 
of the information they will provide. Interviews will be 
conducted at a mutually convenient site. The first author 
will administer the questionnaires and conduct the inter-
views. Each interview will be audio recorded and tran-
scribed verbatim later.
The research team will develop the questionnaire, and 
the interview guide based on the objectives of the process 
evaluation, secondary data on the topic and further 
discussions and brainstorming among the research team. 
The questionnaire and interview guides will be piloted in 
the initial stages of the study to assess suitability for the 
study. As suggested by Given36, interview guides will be 
amended as necessary by the research team.
Management of data
Questionnaire data will be entered into SPSS V.21.0 data 
management and analysis software. Interviews will be digi-
tally recorded and transcribed verbatim. All identifying 
aspects will be removed to maintain anonymity and confi-
dentiality and pseudonyms will be assigned.
Analysis
The quantitative data will be analysed using SPSS (V. 21.0). 
The analysed data will be organised into frequency tables 
and represented on pie charts and tables. The analysis of 
the primary data will be entirely descriptive (summaries, 
frequencies and cross- tabulation tables).
The qualitative data will be analysed thematically. 
The analysis and interpretation of the interviews will be 
Table 2 Methods for objectives
Objective Sample Data collection tool Stage of trial
1. To evaluate the resources, 
structures, and the procedures 
used to deliver the MODEL 
study intervention from the 
perspective of participants.
15–20 trial participant 
interviews. The actual 
sample size will be 
dependent on the point of 
saturation
A semistructured interview guide 
(online supplemental appendix 
1)
Post- baseline 
intervention—1 month after 
participants complete the 
baseline component of the 
intervention
2. To assess participants 
responses to the MODEL study 
intervention and mediating 
processes which may influence 
subsequent changes in 
outcomes.
(a) All 200 participants 
(survey—quantitative 
component) (b) 15–20 trial 
participants interviews
(a) Questionnaire (Mediators- 
perceived risk of CVD, 
perceptions of CVD severity 
and susceptibility and perceived 
self- efficacy online supplemental 
appendix 2) (b) A semistructured 
interview (Responses to 
intervention)
(a) Post- baseline 
intervention—immediately 
after participants complete 
their baseline counselling 
session (b) Post- baseline 
intervention—1 month after 
participants complete the 
baseline component of the 
intervention
3. To better understand the 
contribution of the external 
factors which may influence 
intervention implementation (ie, 
behaviour change).
(a) All 200 participants 
(survey—quantitative 
component) (b) 15–20 trial 
participant interviews
(a) Questionnaire (Demographic 
characteristics). (b) A 
semistructured interview 
(community, social/political, 
family or other situational issues 
outside of the intervention).
(a) Pre- baseline intervention 
(b) Post- baseline 
intervention—1 month after 
participants complete the 
baseline component of the 
intervention
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guided by Huberman and Miles’s framework for thematic 
content analysis.37 The stages will involve the identifica-
tion of meaning units, an initial grouping of meaning 
units into categories, and the creation of emergent 
category names. Following this stage, initial themes will 
be developed using a constant comparison method to 
ensure those meaning units are reflective of emergent 
themes. This will also focus on examining intra- theme 
coherence/consistency and intertheme distinctiveness. 
The first author will lead the analysis and other authors 
will review that analysis and NVivo V.12 software will be 
used to assist the data analysis. Using this software will 
enable the investigators to examine themes and struc-
ture in the content as well as visualise the findings and 
support findings with detailed evidence. An experienced 
qualitative researcher (MSt) will be engaged for peer 
debriefing and member checking will be conducted to 
enhance rigour. Investigators undertaking the MODEL 
RCT’s assessment and counselling (SR- B, CPB, MSi, LB, 
EC, JTS, MPS, JG and BDR) will not be involved in the 
process evaluation data analysis or interpretation. Qual-
itative data will be collected and reported according to 
COREQ guidelines.38
Integration of process and outcomes data
Survey data on contextual factors (participant charac-
teristics) and mediators (perceived risk of CVD, percep-
tions of CVD severity and susceptibility and perceived 
self- efficacy) will be analysed prior to analysis of outcome 
data. After the interviews (on the impact of contextual 
factors such as family, GP, etc) are conducted and anal-
ysed, the process evaluation investigators will be able to 
conclude that the MODEL study intervention has been 
successful by communicating clear information on CVD 
risk and prompting lifestyle/behavioural change. The 
process data will also highlight the role of contextual 
factors and mediators enabling participants to change 
lifestyle/behaviour or not. These data will be used for 
post hoc explanation after trial outcomes are known.
DISCUSSION
This is a detailed protocol for a process evaluation 
embedded within a randomised control trial, the MODEL 
study. The process evaluation will provide useful informa-
tion on the MODEL study intervention and how and why 
the key components/elements (provision of information 
on CVD risk) impacted on lifestyle/behaviour change or 
not. This process evaluation will complement and add 
value to the MODEL study by providing a better insight 
into study results. The investigators of the MODEL 
study will, therefore, be confident after the report of the 
process evaluation data that it is feasible or otherwise to 
use similar approaches to conduct this type of study or 
influence lifestyle/behavioural change. The researchers 
will also derive insight into possible methods for improve-
ment to inform wider implementation strategies as 
demonstrated in previous process evaluations.17 18 39
This process evaluation will employ a comprehensive 
approach to evaluate the resources, structures, and the 
procedures used to deliver the MODEL study interven-
tion. Interviews will be conducted to gather information 
on participants experiences throughout the intervention. 
This would be useful in identifying reasons for lack of 
intervention effect (if any) or any significant changes in 
lifestyle/behaviour. This is in contrast with some other 
process evaluations such as the ProActive study (a phys-
ical activity intervention)19 20, which did not include any 
qualitative component to identify reasons for lack of 
intervention effect and a significant increase in physical 
activity among participants.19 20
Although a mixed- method approach was employed for 
the process evaluation for the Welsh National Exercise 
Referral Scheme intervention,21 the logic model focused 
more on links between intervention activities and mecha-
nisms of impact and only limited focus on delivery mech-
anisms. The MODEL study process evaluation aims to 
focus equally on delivery mechanisms (ie, application of 
resources such as videos and counselling to ensure imple-
mentation), intervention components, mechanisms of 
impact and intended outcomes (behavioural change).
The MODEL study process evaluation also aims to 
gather extensive data on theoretical determinants of 
behaviour change such as risk perception and self- efficacy. 
However, a process evaluation for an adolescent sexual 
health programme intervention in Tanzania22 gathered 
inadequate data on the impact of the intervention on the 
theoretical determinants of behavioural change.
Evaluating and reporting what works for which group 
and what constitutes an effective intervention is an essen-
tial consideration for practitioners, researchers and poli-
cymakers.40 41 The MODEL study process evaluation will 
contribute to existing knowledge and understanding of 
the processes that took place during participation in the 
MODEL study trial. It will also serve as a guide for future 
studies that will be conducted for such complex trials.
STRENGTHS AND LIMITATIONS
This study will employ a comprehensive mixed- method 
approach to evaluate the resources, structures and the 
procedures used to deliver the MODEL study inter-
vention. The process evaluation will assess participants 
responses to the MODEL study intervention and medi-
ating processes which may influence subsequent changes 
in outcomes and identify key contextual (external) factors 
which may influence the process of changing behaviour. 
Core intervention components that were effective in 
influencing lifestyle/behavioural change will be iden-
tified, forming the basis for guidance for replication in 
future studies and implementation in other programmes.
This process evaluation will not evaluate the fidelity 
of the MODEL study and the associated challenges in 
delivery from the perspective of the study investigators. 
Another limitation is the risk of recall bias specifically 
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or possible difficulties on the part of participants recalling 
all information gathered from the intervention. Uninten-
tional responder bias may be attributed to incomplete 
or poor memory recall and intentional responder bias 
may be attributed to embarrassment with admitting truth 
about previous event or nature of disease under investi-
gation. The MODEL study intervention will use several 
resources and procedures in its delivery and it is antic-
ipated that recalling all information gathered from the 
intervention may be a challenge. Also, some participants 
may intentionally give inaccurate details about their life-
style/behavioural change due to the life- threating/life- 
changing nature of CVD or embarrassment associated 
with not changing behaviour.
ETHICS AND DISSEMINATION
The MODEL study process evaluation has received 
approval from the relevant Ethics Committee (Edith 
Cowan University Human Research Ethics Committee 
approval, Project Number: 20513 HODGSON). The study 
results will be shared with the individuals and institutions 
associated with this study as well as academic audiences 
through peer- reviewed publication and presentation at 
conferences.
Author affiliations
1School of Medical and Health Sciences, Edith Cowan University, Joondalup, 
Western Australia, Australia
2Medical School, University of Western Australia, Perth, Western Australia, Australia
3Park Nicollet Osteoporosis Center and Health Partners Institute and Division of 
Health Policy and Management, University of Minnesota, Minneapolis, Minnesota, 
USA
4Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, 
South Australia, Australia
5Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, 
Nedlands, Western Australia, Australia
6INSERM UMR1033, University of Lyon, Lyon, France
7School of Human Sciences (Exercise and Sport Science), University of Western 
Australia, Perth, Western Australia, Australia
8Department of Psychology, College of Healthcare Sciences, James Cook University, 
Townsville, Queensland, Australia
9Hinda and Arthur Marcus Institute for Aging Research, Hebrew Senior Life, Beth 
Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, 
USA
10Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western 
Australia, Australia
11Department of Cardiology, University of Western Australia, Perth, Western 
Australia, Australia
12Institute for Physical Activity and Nutrition, School of Exercise and Nutrition 
Science, Deakin University, Geelong, Victoria, Australia
13Centre for Kidney Research, Children’s Hospital at Westmead, School of Public 
Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, 
Australia
Twitter Amanda Devine @AdMandydevine and Mandy Stanley @stanley_mandy
Contributors RA, SR- B, LCB, MSt., JMH and JRL developed the study concept. 
RA, MSt., JRL, JMH drafted the manuscript. RA, MSt, JRL, LCB, JD, BJ contributed 
to the design of the study and are responsible for study coordination. RA, SR- B, 
JRL, JD, BJ, DPK, JTS and JMH contributed to the design and development of the 
data collection instruments. RA will implement the protocol as well as oversee 
the collection of the qualitative data and will code all transcripts. RA and CPB will 
oversee the collection of the quantitative data. RA, MSi and NPB will be involved in 
the analysis of quantitative data. RA, SR- B, MSi, CPB, EC, RW, KZ, MSt., WHL, PS, 
RMD, KLC, AD, PLT, JG and BDR contributed to the writing of the study content. All 
authors contributed and approved the final manuscript.
Funding The salary of JRL is supported by a National Heart Foundation of Australia 
future leader fellowship (102817). DPK’s time was supported by a grant from the 
National Institute of Arthritis, Musculoskeletal and Skin Diseases (R01 AR 41398). 
The salary of JMH is supported by a National Health and Medical Research 
Council of Australia Senior Research Fellowship (ID 1116973). The salary of LCB is 
supported by an NHMRC of Australia Emerging Leadership Investigator Grant (ID: 
1172987) and a National Heart Foundation of Australia Post- Doctoral Research 
Fellowship (ID: 102498). RA is supported by an Australian Government Research 
Training Program Scholarship (International).
Disclaimer None of the funding agencies had any role in the conduct of the study; 
collection, management, analysis, or interpretation of the data; or preparation, 
review, or approval of the manuscript.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has 
not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been 
peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iDs
Reindolf Anokye http:// orcid. org/ 0000- 0002- 7669- 7057
Simone Radavelli- Bagatini http:// orcid. org/ 0000- 0001- 6821- 5217
Marc Sim http:// orcid. org/ 0000- 0001- 5166- 0605
Mandy Stanley http:// orcid. org/ 0000- 0002- 7958- 5181
REFERENCES
 1 Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med 
2013;369:1336–43.
 2 Mozaffarian D, Capewell S. United Nations’ dietary policies to 
prevent cardiovascular disease. British Medical Journal Publishing 
Group 2011.
 3 Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions 
to promote physical activity and dietary lifestyle changes for 
cardiovascular risk factor reduction in adults: a scientific statement 
from the American heart association. Circulation 2010;122:406–41.
 4 Li X, Ma X, Lin J, et al. Severe carotid artery stenosis evaluated 
by ultrasound is associated with post stroke vascular cognitive 
impairment. Brain Behav 2017;7:e00606.
 5 Giannoukas AD, Chabok M, Spanos K, et al. Screening for 
asymptomatic carotid plaques with ultrasound. Eur J Vasc Endovasc 
Surg 2016;52:309–12.
 6 Weale AR, Urriza- Rodriguez D. Imaging in vascular disease. Surgery 
2015;33:308–14.
 7 Schousboe JT, Lewis JR, Kiel DP. Abdominal aortic calcification 
on dual- energy X- ray absorptiometry: methods of assessment and 
clinical significance. Bone 2017;104:91–100.
 8 Marchal B, Westhorp G, Wong G, et al. Realist RCTs of complex 
interventions - an oxymoron. Soc Sci Med 2013;94:124–8.
 9 Berwick DM. The science of improvement. JAMA 2008;299:1182–4.
 10 Clark AM, MacIntyre PD, Cruickshank J. A critical realist approach 
to understanding and evaluating heart health programmes. Health 
2007;11:513–39.
 11 Pawson R, Tilley N. Realistic evaluation: SAGE. Los Angeles, 
London, New Delhi, Singapore, 1997.
 12 Bonell C, Fletcher A, Morton M, et al. Realist randomised controlled 
trials: a new approach to evaluating complex public health 

















pen: first published as 10.1136/bm






8 Anokye R, et al. BMJ Open 2020;10:e036395. doi:10.1136/bmjopen-2019-036395
Open access 
 13 Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating 
complex interventions: the new medical Research Council guidance. 
BMJ 2008;337:a1655.
 14 Moore GF, Audrey S, Barker M, et al. Process evaluation of 
complex interventions: medical Research Council guidance. BMJ 
2015;350:h1258.
 15 Oakley A, Strange V, Bonell C, et al. Process evaluation in 
randomised controlled trials of complex interventions. BMJ 
2006;332:413–6.
 16 Wight D, Obasi A. Unpacking the black box: the importance of 
process data to explain outcomes 2003.
 17 van Dongen EJ, Duijzer G, Jansen SC, et al. Process evaluation of 
a randomised controlled trial of a diabetes prevention intervention 
in Dutch primary health care: the slimmer study. Public Health Nutr 
2016;19:3027–38.
 18 Arends RY, Bode C, Taal E, et al. A mixed- methods process 
evaluation of a goal management intervention for patients with 
polyarthritis. Psychol Health 2017;32:38–60.
 19 Hardeman W, Michie S, Fanshawe T, et al. Fidelity of delivery of a 
physical activity intervention: predictors and consequences. Psychol 
Health 2008;23:11–24.
 20 Michie S, Hardeman W, Fanshawe T, et al. Investigating theoretical 
explanations for behaviour change: the case study of proactive. 
Psychol Health 2008;23:25–39.
 21 Moore GF, Raisanen L, Moore L, et al. Mixed- method process 
evaluation of the Welsh national exercise referral scheme. health 
education 2013.
 22 Plummer ML, Wight D, Obasi AIN, et al. A process evaluation of a 
school- based adolescent sexual health intervention in rural Tanzania: 
the MEMA kwa Vijana programme. Health Educ Res 2007;22:500–12.
 23 Linnan L, Steckler A. Process evaluation for public health 
interventions and research 2002.
 24 Michie S, Johnston M, Francis J, et al. From theory to intervention: 
mapping theoretically derived behavioural determinants to behaviour 
change techniques. Appl Psychol 2008;57:660–80.
 25 Wallace LM, Brown KE, Hilton S. Planning for, implementing and 
assessing the impact of health promotion and behaviour change 
interventions: a way forward for health psychologists. Health Psychol 
Rev 2014;8:8–33.
 26 Reijneveld SA. Neighbourhood socioeconomic context and self 
reported health and smoking: a secondary analysis of data on seven 
cities. J Epidemiol Community Health 2002;56:935–42.
 27 Duncan C, Jones K, Moon G. Smoking and deprivation: are there 
neighbourhood effects? Soc Sci Med 1999;48:497–505.
 28 Stimpson JP, Ju H, Raji MA, et al. Neighborhood deprivation 
and health risk behaviors in NHANES III. Am J Health Behav 
2007;31:215–22.
 29 Boone- Heinonen J, Gordon- Larsen P, Kiefe CI, et al. Fast food 
restaurants and food stores: longitudinal associations with diet in 
young to middle- aged adults: the cardia study. Arch Intern Med 
2011;171:1162–70.
 30 Skidmore P, Welch A, van Sluijs E, et al. Impact of neighbourhood 
food environment on food consumption in children aged 9-10 years 
in the UK speedy (sport, physical activity and eating behaviour: 
environmental determinants in young people) study. Public Health 
Nutr 2010;13:1022–30.
 31 Gordon- Larsen P, Nelson MC, Page P, et al. Inequality in the built 
environment underlies key health disparities in physical activity and 
obesity. Pediatrics 2006;117:417–24.
 32 Champion VL, Skinner CS. The health belief model. Health behavior 
and health education: Theory, research, and practice 2008;4:45–65.
 33 Patton MQ. Qualitative evaluation and research methods. SAGE 
Publications, inc, 1990.
 34 Liamputtong P, Serry T. Making sense of qualitative data. research 
methods in health. Foundations for evidence- based practice 
2013:365–79.
 35 Brinkmann S. Qualitative interviewing: Oxford university press 2013.
 36 Given LM. 100 questions (and answers) about qualitative research: 
SAGE publications 2015.
 37 Huberman AM, Miles MB. Data management and analysis methods 
1994.
 38 Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting 
qualitative research (COREQ): a 32- item checklist for interviews and 
focus groups. Int J Qual Health Care 2007;19:349–57.
 39 Audrey S, Holliday J. Parry- Langdon N. a stop smoking in schools 
trial (assist): process evaluation manual. Bristol: Cardiff University and 
University of Bristol, 2003.
 40 Berlin LJ, Brooks- Gunn J, Aber JL. Promoting early childhood 
development through comprehensive community initiatives. 
Children's Services 2001;4:1–24.
 41 Nicholson JM, Berthelsen D, Williams KE, et al. National study of an 
early parenting intervention: implementation differences on parent 


















pen: first published as 10.1136/bm






 INTERVIEW QUESTIONS 
1. Tell me about how you came to be involved in this study. 
Prompt 
• Tell me more about that, what was it that interested you?  
• Why was that? 
  
2. What do you remember about the videos? 
 
3. What did you think of the 3 videos (Heart Foundation, Cardiovascular and D&L) and 
information booklet provided to you in the counselling session (E.g. duration, clarity 
of the language used and expressions, etc.)? 
  
4. Please describe your initial reaction to seeing your own level of advanced blood 
vessel disease (AAC) for the first time (i.e., the image, illustrative representation and 
information about your cardiovascular disease status)? 
  
5. What was the immediate effect, if any, that this image/information had on you?  
Prompt 
• How did it make you feel?  
• Can you please explain why and how? 
  
6. What was the immediate effect, if any, that the dietary and lifestyle counselling had 
on you?  
Prompt 
• How did it make you feel?  
• Can you please explain why and how? 
  
7. How has the image/information on your own level of advanced blood vessel disease 
changed your behaviour?      
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Prompt                                                                                                
• If so, why and how?  
• What was the easiest/hardest part of making the changes, and why?  
• In what ways?  
• Can you share with me some examples? 
 
8. Did you share your results with healthcare providers?  
Prompt 
• If so, what did they say and how did it make you feel?  
• Can you please explain why and how?   
• If you haven’t discussed it yet, are you planning on discussing the results with 
your GP? 
  
9. Did you share your results with family and friends?  
Prompt 
• If so, what did they say and how did it make you feel?  
• Can you please explain why and how? 
  
10. So what or which specific parts of the diet and lifestyle video were helpful to you? 
Prompt 
• What recommendations do you have for improving its delivery? 
  
11. What other elements of the consultation (i.e., non-AAC materials, such as BP, lipids, 
and interaction with the counsellor, booklet) influenced your feelings or behaviour?  
Prompt 
• If so, how and why, and if not, why not?  
• What element of the consultation has influenced you most (if any)? 
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12. What other information provided was helpful for you?  
How?  
       Prompt 
• What recommendations do you have about how best to present the advanced 
blood vessel disease image/information?  
• What questions did you have after being presented with the image/information 
(if any)? 
  
13. Is there anything else you wanted to say about the duration, clarity of the language 
used and expressions in the 3 videos, the counselling sessions and any other 
information in this study? 
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To be answered at end of conversation – counselling visit 3, once all elements have been completed 
 
A) For each of the following statements, please indicate to what extent you agree with that statement, 












1. The information provided made me think that I 
am susceptible to cardiovascular disease 
1 2 3 4 5 
2. The information provided made me think that I 
am at risk of cardiovascular disease 
1 2 3 4 5 
3. The information provided made me feel that my 
health is at risk 
1 2 3 4 5 
4. Having cardiovascular problems is a severe health 
problem 
1 2 3 4 5 
5. Having cardiovascular problems is a significant 
health risk 
1 2 3 4 5 
6. Having cardiovascular problems is serious for my 
health 
1 2 3 4 5 
 
B) For each of the following statements, please indicate how each sentence best applies to you, using 
the scales: 
 Poor Fair Good Very 
good 
Excellent 





Low level Moderate 
level 
High level Very high 
level 
8. Please estimate your level of atherosclerosis 1 2 3 4 5 
 
 
Sticker with Participant’s ID,  




Visit:    1      2      3      4      5         Date of visit: _____/_____/_____ 
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9. How certain are you of your level of 
atherosclerosis? 
1 2 3 4 5 
 
C) The following questions refer to the 3 goals on diet and physical activity. For each of the following 












10. Meeting the goal for fruit and vegetable intake 
will reduce my risk of cardiovascular problems 
1 2 3 4 5 
11. Meeting the goal for fruit and vegetable intake is 
one of the most important things I can do to protect 
my cardiovascular health 
1 2 3 4 5 
12. Meeting the other dietary goal (e.g., reducing salt, 
alcohol, processed meats, and increasing grains and 
nuts) will reduce my risk of cardiovascular problems 
1 2 3 4 5 
13. Meeting the other dietary goal (e.g., reducing salt, 
alcohol, processed meats, and increasing grains and 
nuts) is one of the most important things I can do to 
protect my cardiovascular health 
1 2 3 4 5 
14. Meeting the goal to increase physical activity and 
reduce sitting time will reduce my risk of 
cardiovascular problems 
1 2 3 4 5 
15. Meeting the goal to increase physical activity and 
reduce sitting time is one of the most important things 
I can do to protect my cardiovascular health 
1 2 3 4 5 
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D) The following questions refer to the 3 goals on diet and physical activity. For each of the following 












16. Right now, I think I can meet the goal for fruit and 
vegetable intake 
1 2 3 4 5 
17. Right now, I am confident in my ability to meet 
the goal for fruit and vegetable intake 
1 2 3 4 5 
18. Right now, I think I can meet the other dietary 
goal (e.g., reducing salt, alcohol, processed meats, and 
increasing grains and nuts) 
1 2 3 4 5 
19. Right now, I am confident in my ability to meet 
the other dietary goal (e.g., reducing salt, alcohol, 
processed meats, and increasing grains and nuts) 
1 2 3 4 5 
20. Right now, I think I can meet the goal to increase 
physical activity and reduce sitting time 
1 2 3 4 5 
21. Right now, I am confident in my ability to meet 
the goal to increase physical activity and reduce sitting 
time 
1 2 3 4 5 
 
E) The following questions refer to your intentions towards dietary and lifestyle advice. For each of the 













22. I intend to meet the goal for fruit and vegetable 
intake 
1 2 3 4 5 
23. I intend to meet the other dietary goal (e.g., 
reducing salt, alcohol, processed meats, and 
increasing grains and nuts) 
1 2 3 4 5 
24. I intend to meet the goal to increase physical 
activity and reduce sitting time 







Entered on: ____/____/____ by __________ 
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